Cited by 3Clinical practice guidelines implementationPeripheral Neuropathies and DisordersHealthcare cost, quality, practices

An analysis of AAN′s evidence-based guideline for IVIg use in neurologic disorders: Provider impact and payer perspectives

Open access
Satya-Murti, Saty, Shepard, Katie M., Kaufman, Joel M.·2012·Neurology Clinical Practice

Abstract

Health insurers look for reliable, published evidence such as evidence-based guidelines put forth by medical specialty societies to craft their coverage policies. These guidelines generate both beneficial and controversial consequences on policies. Coverage policies aim to address the most typical clinical presentations. The American Academy of Neurology guideline for IV immunoglobulin strengthens the case for coverage when it is used to treat Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. The guideline is less likely to strengthen coverage for several other diagnoses with lower levels of evidence. The responsibility to clarify specific situations when patient need falls outside of what is considered to be routine evaluation or treatment rests heavily on the physician. Advice on appealing an unfavorable coverage decision is also provided to the reader.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/cpj.0b013e31825a77ca

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • When a patient has comorbidities or unusual features outside routine evaluation or treatment, clinicians often must provide additional justification or supporting documentation to request individual consideration or challenge unfavorable coverage decisions.

    “However, when a patient has comorbidities or unusual features that fall outside routine evaluation or treatment, it is often the clinician who must provide additional justification or supporting documentation to request individual consideration or to challenge unfavorable coverage decisions [321].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Satya-Murti, S., Shepard, K. M., & Kaufman, J. M.
Affiliations
  • Health Policy Consultant (SS-M), Santa Maria, CA; American Academy of Neurology (KMS), Minneapolis, MN; and Department of Neurology (JMK), Rhode Island Hospital and The Warren Alpert Medical School of Brown University, Providence, RI.
  • Brown University (US)
Corresponding author
Shepard, Katie M.
Venue
Neurology Clinical Practice
Published
2012-06
Volume
2
Issue
2
Pages
134-138
ISSN
  • 2163-0402 (ISSN-L)
  • 2163-0933
OpenAlex
W1966771430
Cited by
3
References
9
Citations by year
2026: 1 · 2022: 1 · 2018: 1
FWCI
0.00
Type
journal article
Language
en
Open access
Locations
  • Neurology Clinical Practice (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Yale University
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
  • Health Sciences › Medicine › Neurology › Peripheral Neuropathies and Disorders
  • Health Sciences › Health Professions › General Health Professions › Healthcare cost, quality, practices
Keywords
intravenous immunoglobulin, insurance coverage, health insurance policy, American Academy of Neurology guidelines, Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, evidence-based recommendations, neurological disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review